• 1
    Statistics Canada. Health status of Canadians, report of the 1991 General Social Survey. Catalogue no. 11–612E, No. 8. Ottawa: Supply and Services, Canada; 1994.
  • 2
    Lee P. The economic impact of musculoskeletal disorders. Qual Life Res 1994; 3: S8591.
  • 3
    Felts W, Yelin E. The economic impact of rheumatic diseases in the United States. J Rheumatol 1989; 16: 86784.
  • 4
    Badley EM, Arnold J, Webster G. Arthritis in Ontario: a study of intra-provincial variation. Working paper 94–1, February. Toronto: Arthritis Community Research and Evaluation Unit; 1994.
  • 5
    Felson DT, Naimark A, Anderson J, Kazis L, Castelli W, Meenan RF. The prevalence of knee osteoarthritis in the elderly: the Framingham Osteoarthritis Study. Arthritis Rheum 1987; 30: 9148.
  • 6
    Gordon T. Osteoarthritis in US adults. In: BennettPH, WoodPHN, editors. Population studies of rheumatic diseases. Amsterdam: Excerpta Medica Foundation; 1968. p. 3917.
  • 7
    Mikkelsen WM, Duff IF, Dodge HJ. Age-sex prevalence of radiographic abnormalities of the joints of the hands, wrists and cervical spine of adult residents of the Tecumseh, Michigan Community Health Study area, 1962–1965. J Chronic Dis 1970; 23: 1519.
  • 8
    Badley EM, Webster GK, Rasooly I. The impact of musculoskeletal disorders in the population: are they aches and pains? Findings from the 1990 Ontario Health Survey. J Rheumatol 1995; 22: 7339.
  • 9
    Reynolds DL, Chambers LW, Badley EM, Bennett KJ, Goldsmith CH, Jamieson E, et al. Physical disability among Canadians reporting musculoskeletal diseases. J Rheumatol 1992; 19: 102030.
  • 10
    Cunningham LS, Kelsey JL. Epidemiology of musculoskeletal impairments and associated disability. Am J Public Health 1984; 74: 5749.
  • 11
    Verbrugge LM. Physical and social disability in adults. In: HibbardHH, NuttingPA, GradyML, editors. Functional and health status measures for primary care. Washington (DC): US Department of Health and Human Services; 1991. p. 3157.
  • 12
    McAlindon TE, Cooper C, Kirwan JR, Dieppe PA. Knee pain and disability in the community. Br J Rheumatol 1992; 31: 18992.
  • 13
    Bridges-Webb C, Britt H, Miles DA, Neary S, Charles J, Traynor V. Morbidity and treatment in general practice in Australia 1990–1991. Med J Aust 1992; 157 Suppl: S156.
  • 14
    Peyron JG, Altman RD. The epidemiology of osteoarthritis. In: MoskowitzRW, HowellDS, GoldbergVM, MankinHJ, editors. Osteoarthritis: diagnosis and medical/surgical management. 2nd ed. Toronto: WB Saunders Company; 1992. p. 1537.
  • 15
    Kramer JS, Yelin EH, Epstein WV. Social and economic impacts of four musculoskeletal conditions: a study using national community-based data. Arthritis Rheum 1983; 26: 9017.
  • 16
    Liang MH, Larson M, Thompson M, Eaton H, McNamara E, Katz R, et al. Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 1984; 27: 5229.
  • 17
    Pincus T, Mitchell JM, Burkhauser RV. Substantial work disability and earnings losses in individuals less than age 65 with osteoarthritis: comparisons with rheumatoid arthritis. J Clin Epidemiol 1989; 42: 44957.
  • 18
    Hadler NM. Osteoarthritis as a public health problem. Clin Rheum Dis 1985; 11: 17585.
  • 19
    Moskowitz RW, Howell DS, Goldberg VM, Mankin HJ. Osteoarthritis: diagnosis and medical/surgical management. 2nd ed. Toronto: WB Saunders Company; 1992.
  • 20
    Badley EM, Wang PP. Arthritis and the aging population: projections of arthritis prevalence in Canada 1991 to 2031. J Rheumatol 1998; 25: 13844.
  • 21
    Yelin E, Callahan LF, for the National Arthritis Data Work Group. The economic cost and social and psychological impact of musculoskeletal conditions. Arthritis Rheum 1995; 38: 135162.
  • 22
    Rice D. Cost of musculoskeletal conditions. In: PraemerA, FurnerS, RiceD, editors. Musculoskeletal conditions in the United States. Chicago: American Academy of Orthopaedic Surgeons; 1992. p. 14370.
  • 23
    Wigle DT, Mao Y, Wong T, Lane R. Economic burden of illness in Canada, 1986. Chronic Dis Can 1991; 12 Suppl: 137.
  • 24
    Badley EM. The economic burden of musculoskeletal disorders in Canada is similar to that for cancer, and may be higher. J Rheumatol 1995; 22: 2046.
  • 25
    Rice DP. Cost-of-illness studies: fact or fiction? Lancet 1994; 344: 151920.
  • 26
    Boyle MH, Torrance GW, Sinclair J, Horwood S. Economic evaluation of neonatal intensive care of very low birth weight infants. N Engl J Med 1983; 308: 13307.
  • 27
    Drummond MF, Stoddart GL, Torrance GW. Methods for the economic evaluation of health care programs. Oxford: Oxford University Press; 1988.
  • 28
    Chan B, Coyte PC, Heick C. The economic costs of cardiovascular disease in Canada. Can J Cardiol 1996; 12: 17.
  • 29
    Moore R, Mao Y, Zhang J, Clarke K. Economic burden of illness in Canada, 1993. Catalogue no. H21–136/1993E. Ottawa: Health Canada; 1997.
  • 30
    Asche C, Coyte PC, Hawker G, Chan B. The economic cost and social and psychological impact of musculoskeletal conditions: comment on the article by Yelin et al [letter]. Arthritis Rheum 1997; 39: 1931.
  • 31
    World Health Organization. International classification of diseases, 9th revision, clinical modification. Geneva: World Health Organization; 1986.
  • 32
    World Health Organization. International classification of diseases. Geneva: World Health Organization; 1977.
  • 33
    Health Canada. National health expenditures in Canada: 1975–1993. Ottawa: Supply and Services, Canada; 1994.
  • 34
    Manitoba Health. Medical services and costs by diagnostic classification, sex, and age group, 1993/94. Winnipeg: Health Information Systems Branch; 1996.
  • 35
    Intercontinental Medical Statistics Canada. Canadian disease and therapeutic index, diagnosis, 1994. Montreal: Intercontinental Medical Statistics Canada; 1996.
  • 36
    Canadian Pharmaceutical Association. Provincial drug benefit management programs and provincial pharmaceutical associations. Ottawa: Canadian Pharmaceutical Association; 1996.
  • 37
    Medical Research Council of Canada. Reference list of health science research in Canada 1993–1994. Catalogue No. MRI-71/1994. Ottawa: Medical Research Council of Canada; 1994.
  • 38
    Statistics Canada. Hospital morbidity data. Ottawa: Statistics Canada, Health Statistics Division, Client Customer Services; 1996.
  • 39
    Statistics Canada. Residential care facilities-aged, 1992/93. Catalogue No. 83–237. Ottawa: Supply and Services, Canada; 1994.
  • 40
    Robinson JC. Philosophical origins of the economic evaluation of life. Milbank Q 1986; 64: 13355.
  • 41
    Hodgson T, Meiners M. Cost-of-illness methodology: a guide to current practices and procedures. Milbank Q 1982; 60: 42962.
  • 42
    Statistics Canada. Causes of death, 1993–1994. Ottawa: Supply and Services, Canada, Special Request Unit; 1996.
  • 43
    Statistics Canada. Income distributions by size in Canada, 1993. Catalogue No. 13–207. Ottawa: Household Surveys Division, Statistics Canada; 1994.
  • 44
    Statistics Canada. Canada pension plan/old age security. Stat Bull 1994; 112.
  • 45
    Regie des Rentes du Quebec. Le Regime de Rentes du Quebec: statistique 1993. Quebec: Regie des Rentes du Quebec; 1994.
  • 46
    Canadian Life and Health Association. Health insurance benefits in Canada. Ottawa: Canadian Life and Health Association; 1993.
  • 47
    Schulpher MJ, Buxton MJ, Ferguson BA, Spiefelhalte DJ, Kirby AJ. Screening for diabetic retinopathy: a relative cost-effectiveness analysis of alternative modalities and strategies. Health Econ 1992; 1: 3951.
  • 48
    Torgerson DJ, Donaldson C, Reid DM. Private versus social opportunity cost of time: valuing time in the demand for health care. Health Econ 1994; 3: 14955.
  • 49
    Statistics Canada. Individuals outside the labour force by age and gender, 1992/93. Ottawa: Statistics Canada, Health Statistics Division, Client Customer Services; 1996.
  • 50
    Ontario Ministry of Health. Ontario health survey user's guide, vol. 2: microdata manual. Toronto: Queen's Printer; 1993.
  • 51
    Badley EM, Rasooly I, Webster GK. Relative importance of musculoskeletal disorders as a cause of chronic health problems, disability, and health care utilization: findings from the 1990 Ontario Health Survey. J Rheumatol 1994; 21: 50514.
  • 52
    Wilkins R, Adams OB. Healthfulness of life: a unified view of mortality, institutionalization, and non-institutionalized disability in Canada, 1978. Montreal: Institute for Research on Public Policy; 1983.
  • 53
    Scitovsky AA. Estimating the direct costs-of-illness. Milbank Q 1982; 60: 46391.
  • 54
    Glied S. Estimating the indirect cost of illness: an assessment of the foregone earnings approach. Am J Public Health 1996; 86: 17238.
  • 55
    Sheill A, Gerard K, Donaldson C. Cost-of-illness studies: no aid to decision making? Health Policy 1987; 8: 31723.
  • 56
    Behrens C, Henke KD. Cost-of-illness studies: no aid to decision making? Reply. Health Policy 1988; 10: 13741.
  • 57
    Hodgson TA. Cost-of-illness studies: no aid to decision making? Comment on the second opinion by Sheill et al. Health Policy 1989; 11: 5760.